ATF5 and glioma: With respect to brain tumor cells, Sheng et al. [29] showed that ATF5 over-expression protected murine GL261 glioma cells from a variety of apoptotic stimuli including inhibitors of FGFR, EGFR, RAS or PI3K as well as from the kinase inhibitor sorafenib.